Erbi Biosystems

Erbi Biosystems Focuses on Providing Tools for Therapeutic Drug Manufacturers to Accelerate the Development of Their Processes and Therapies.Erbi Biosystems launched its first product, the microfluidic automation system Breez bioreactor, in 2020. Breez offers concentrated cell density performance that is unparalleled at this scale. It is the ideal choice for scaling up aggregate batch and continuous processing.Erbi Biosystems' technology will expand to cover all scaled-down unit operations in bioprocessing—significantly reducing the time and lab space required for process development. The platform's ability to handle small batches and automate processes holds the potential to transform CAR-T and other autologous therapies, in addition to traditional drugs and biologics.